Enzolytics Stock Analysis

Enzolytics Pink Sheet Analysis Notes

The company recorded a loss per share of 4.76. Enzolytics had not issued any dividends in recent years. The entity had 1:500 split on the 7th of February 2013. Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Enzolytics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Enzolytics call Harry Zhabilov at 972 292 9414 or check out https://enzolytics.com.

Enzolytics Investment Alerts

Enzolytics Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 125.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enzolytics's market, we take the total number of its shares issued and multiply it by Enzolytics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 24th of November, Enzolytics shows the Standard Deviation of 7.19, mean deviation of 5.97, and Variance of 51.67. Enzolytics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Enzolytics Price Movement Analysis

Enzolytics Outstanding Bonds

Enzolytics Predictive Daily Indicators

Enzolytics Forecast Models

Enzolytics' time-series forecasting models are one of many Enzolytics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enzolytics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Enzolytics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enzolytics shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Enzolytics. By using and applying Enzolytics Pink Sheet analysis, traders can create a robust methodology for identifying Enzolytics entry and exit points for their positions.

When running Enzolytics' price analysis, check to measure Enzolytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzolytics is operating at the current time. Most of Enzolytics' value examination focuses on studying past and present price action to predict the probability of Enzolytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzolytics' price. Additionally, you may evaluate how the addition of Enzolytics to your portfolios can decrease your overall portfolio volatility.